カテゴリ： MarketLine, アメリカ, 企業調査

Marsh & McLennan Companies, Inc.：企業の戦略・SWOT・財務情報

◆英語タイトル：Marsh & McLennan Companies, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C1136
◆発行会社（調査会社）：MarketLine
◆発行日：2018年7月
◆ページ数：59
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Marsh & McLennan Companies, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Marsh & McLennan Companies, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Marsh & McLennan Companies, Inc. (MMC) is a professional services group. It offers solutions for strategy, risk, and human capital. The group offers insurance broking and risk advisory through Marsh; risk and reinsurance intermediary services through Guy Carpenter; and human resources and investment related financial advice and services through Mercer. It also offers management consulting, economic analysis and advice, and brand strategy and design consulting services through Oliver Wyman. The group serves individuals, businesses, professional service organizations and government entities. It operates in the US, the UK, Europe, and Asia Pacific. MMC is headquartered in New York City, New York, the US.

Scope

- Detailed information on Marsh & McLennan Companies, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Marsh & McLennan Companies, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Marsh & McLennan Companies, Inc. including a breakdown and examination of key business segments
- Intelligence on Marsh & McLennan Companies, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Marsh & McLennan Companies, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Marsh & McLennan Companies, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Marsh & McLennan Companies, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Marsh & McLennan Companies, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Marsh & McLennan Companies, Inc.: Company Overview 9
Marsh & McLennan Companies, Inc.: Overview and Key Facts 9
Marsh & McLennan Companies, Inc.: Overview 9
Marsh & McLennan Companies, Inc.: Key Facts 9
Marsh & McLennan Companies, Inc.: Key Employees 11
Marsh & McLennan Companies, Inc.: Key Employee Biographies 13
Marsh & McLennan Companies, Inc.: Major Products and Services 20
Marsh & McLennan Companies, Inc.: Company History 21
Marsh & McLennan Companies, Inc.: Management Statement 25
Marsh & McLennan Companies, Inc.: Locations and Subsidiaries 31
Marsh & McLennan Companies, Inc.: Key Competitors 35
Marsh & McLennan Companies, Inc.: Company Analysis 36
Marsh & McLennan Companies, Inc.: Business Description 36
Marsh & McLennan Companies, Inc.: SWOT Analysis 37
Marsh & McLennan Companies, Inc.: SWOT Overview 37
Marsh & McLennan Companies, Inc.: Strengths 37
Marsh & McLennan Companies, Inc.: Weaknesses 38
Marsh & McLennan Companies, Inc.: Opportunities 38
Marsh & McLennan Companies, Inc.: Threats 39
Marsh & McLennan Companies, Inc.: Corporate Financial Deals Activity 41
Marsh & McLennan Companies, Inc.: Financial Deals Overview 41
Marsh & McLennan Companies, Inc.: Targets and Partners 43
Marsh & McLennan Companies, Inc.: Top Deals 2014 – 2018YTD* 44
Marsh & McLennan Companies, Inc.: Advisors 45
Marsh & McLennan Companies, Inc.: Top Legal Advisors 45
Marsh & McLennan Companies, Inc.: Top Financial Advisors 45
Marsh & McLennan Companies, Inc.: Mergers and Acquisitions 47
Marsh & McLennan Companies, Inc.: Capital Raising 48
Marsh & McLennan Companies, Inc.: Recent Developments 49
Marsh & McLennan Companies, Inc.: News and Events Summary 49
Marsh & McLennan Companies, Inc.: Business Expansion 52
Marsh & McLennan Companies, Inc.: Contracts 52
Marsh & McLennan Companies, Inc.: Corporate Governance 53
Marsh & McLennan Companies, Inc.: Financial Deals 54
Marsh & McLennan Companies, Inc.: Financial Performance 55
Marsh & McLennan Companies, Inc.: Strategy and Operations 56
Appendix 57
Contact Us 57
Methodology 57
About MarketLine 58

List of Tables
Table 1: Marsh & McLennan Companies, Inc.: Key Facts
Table 2: Marsh & McLennan Companies, Inc.: Key Employees
Table 3: Marsh & McLennan Companies, Inc.: Locations and Subsidiaries
Table 4: Marsh & McLennan Companies, Inc.: Key Competitors
Table 5: Marsh & McLennan Companies, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Marsh & McLennan Companies, Inc.: M&A Activity by Geography (TTM*)
Table 7: Marsh & McLennan Companies, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Marsh & McLennan Companies, Inc.: Targets and Partners
Table 9: Marsh & McLennan Companies, Inc.: Top Deals 2014 - 2018YTD*
Table 10: Marsh & McLennan Companies, Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: Marsh & McLennan Companies, Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: Marsh & McLennan Companies, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Marsh & McLennan Companies, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Marsh & McLennan Companies, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 15: Marsh & McLennan Companies, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 16: Marsh & McLennan Companies, Inc.: News and Events Summary
Table 17: Marsh & McLennan Companies, Inc.: Business Expansion
Table 18: Marsh & McLennan Companies, Inc.: Contracts
Table 19: Marsh & McLennan Companies, Inc.: Corporate Governance
Table 20: Marsh & McLennan Companies, Inc.: Financial Deals
Table 21: Marsh & McLennan Companies, Inc.: Financial Performance
Table 22: Marsh & McLennan Companies, Inc.: Strategy and Operations

List of Figures
Figure 1: Marsh & McLennan Companies, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Marsh & McLennan Companies, Inc.: M&A Activity by Geography (TTM*)
Figure 3: Marsh & McLennan Companies, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Marsh & McLennan Companies, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Marsh & McLennan Companies, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Marsh & McLennan Companies, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 7: Marsh & McLennan Companies, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Marsh & McLennan Companies, Inc.：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Inventiva (IVA)：製薬・医療：M&Aディール及び事業提携情報
    Summary Inventiva is a clinical stage biopharmaceutical company that discovers and develops therapies for fibrosis, oncology and orphan diseases. The company develops pipeline products for nonalcoholic steatohepatitis, systemic sclerosis, mucopolysaccharidosis, moderate to severe psoriasis, malignan …
  • Boston Children’s Hospital-製薬・医療分野：企業M&A・提携分析
    Summary Boston Children's Hospital (Boston Children’s) is the pediatric medical center that provides a comprehensive range of health care services for children from birth through 21 years of age. Boston Children’s is the primary pediatric teaching affiliate of Harvard Medical School. The organizatio …
  • Genoptix Inc-製薬・医療分野：企業M&A・提携分析
    Summary Genoptix Inc (Genoptix) is a healthcare services provider that offers diagnostic solutions. The center offers oncology diagnostics and informatics services. It provides biopharma and healthcare laboratory, discovery, drug development, care and cost development; diagnostics, and patient servi …
  • Congenica Ltd：医療機器：M&Aディール及び事業提携情報
    Summary Congenica Ltd (Congenica) is a biotechnology company that offers clinical decision support software and services. The company provides research and experimental development on biotechnology. Its technology SAPIENTIA is used to personalize patient care through accurate diagnoses, drug develop …
  • Bilfinger Tebodin BV：企業の戦略的SWOT分析
    Bilfinger Tebodin BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Asahi Kasei Corp (3407)：企業の財務・戦略的SWOT分析
    Asahi Kasei Corp (3407) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Nova Ljubljanska banka d.d.：企業の戦略・SWOT・財務分析
    Nova Ljubljanska banka d.d. - Strategy, SWOT and Corporate Finance Report Summary Nova Ljubljanska banka d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • John Keells Hotels Plc
    John Keells Hotels Plc - Strategy, SWOT and Corporate Finance Report Summary John Keells Hotels Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Astron Corp Ltd (ATR)：企業の財務・戦略的SWOT分析
    Astron Corp Ltd (ATR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • PT Dirgantara Indonesia：企業の戦略・SWOT・財務情報
    PT Dirgantara Indonesia - Strategy, SWOT and Corporate Finance Report Summary PT Dirgantara Indonesia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Bechtle AG (BC8)：企業の財務・戦略的SWOT分析
    Summary Bechtle AG (Bechtle) is an information technology (IT) products retailer. The company offers various productswhich include notebooks, tablets, smartphones, mobile phones, wearables, power banks, spare parts, accessories, monitors, public display, projectors, input devises, scanners, barcode …
  • Biomatlante SA：企業の製品パイプライン分析
    Summary Biomatlante SA (Biomatlante) operates as a biologics solutions provider that manufactures, develops, and commercializes synthetic bone graft technologies and synthetic biomaterials for bone regeneration. The company’s products include inserts, granules, sticks, wedges, syringes, putty, screw …
  • Real Matters Inc (REAL)：企業の財務・戦略的SWOT分析
    Real Matters Inc (REAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • China Everbright Ltd (165)：企業の財務・戦略的SWOT分析
    China Everbright Ltd (165) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • TWi Pharmaceuticals Inc (4180)：製薬・医療：M&Aディール及び事業提携情報
    Summary TWi Pharmaceuticals Inc (TWi), formerly Anchen Pharmaceuticals (Taiwan) Inc is a technology based pharmaceutical company that manufactures high barrier generics drugs. The company provides products such as donepezil hydrochloride tablets, hydroquinone cream, hydroquinone time release cream, …
  • Yanmar Co Ltd：企業の戦略的SWOT分析
    Yanmar Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Gulfport Energy Corp (GPOR)：石油・ガス：M&Aディール及び事業提携情報
    Summary Gulfport Energy Corp (Gulfport) is an oil and gas company that explores, develops and produces oil and natural gas. The company operates its oil and gas exploration and development assets in Utica Shale, West Cote Blanche Bay Field, Hackberry Field, Athabasca, Peace River oil and Cold Lake o …
  • Impresario Entertainment and Hospitality Pvt., Ltd.：企業の戦略・SWOT・財務情報
    Impresario Entertainment and Hospitality Pvt., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Impresario Entertainment and Hospitality Pvt., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's stru …
  • IntelGenx Corp：企業のM&A・事業提携・投資動向
    IntelGenx Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's IntelGenx Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Finox AG：製薬・医療：M&Aディール及び事業提携情報
    Summary Finox AG (Finox), a subsidiary of Richter Gedeon Nyrt, is a drug development and manufacturing company that offers fertility treatment products. The company develops drugs in the field of fertility therapies. Its product portfolio includes biosimilars and patient friendly delivery devices. F …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆